Research map: Systemic Inflammation and Risk of Thromboembolism, Mortality, and Treatment Response in Patients With Cancer Receiving Immune Checkpoint Inhibitors

Back to the article

Papers in this map

  1. New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1) · E. A. Eisenhauer · 2008 · 30146 citations · Cited by this paper
  2. A Comprehensive Meta‐Analysis of Bioadaptor Versus Drug‐Eluting Stents in Randomised Trials With Exploratory Single‐Arm Landmark Analyses · 2026 · Related
  3. Immunity, Inflammation, and Cancer · Sergei I. Grivennikov · 2010 · 10892 citations · Cited by this paper
  4. FNDC4 and FNDC5 Attenuate SARS‐CoV‐2 S1‐Induced Inflammatory Responses in Human Adipose Tissue · 2026 · Related
  5. Inflammation and Cancer: Triggers, Mechanisms, and Consequences · Florian R. Greten · 2019 · 3885 citations · Cited by this paper
  6. Practical considerations for the use of vericiguat in older patients with heart failure and reduced ejection fraction · 2026 · Related
  7. Interplay between inflammation and thrombosis in cardiovascular pathology · Konstantin Stark · 2021 · 1040 citations · Cited by this paper
  8. Causal Effects of Time‐Varying Treatments: The G‐Formula · 2026 · Related
  9. Prediction of venous thromboembolism in cancer patients · Cihan Ay · 2010 · 782 citations · Cited by this paper
  10. Introduction · 2026 · Related
  11. Platelets at the interface of thrombosis, inflammation, and cancer · Aime T. Franco · 2015 · 712 citations · Cited by this paper
  12. Transplantation's Paradox: Life‐Saving Procedure, Life‐Changing Risks: An Editorial on ‘Colorectal Cancer in Heart Transplant Recipients’ · 2026 · Related
  13. Cancer-associated venous thromboembolism · Alok A. Khorana · 2022 · 476 citations · Cited by this paper
  14. Why Osteosarcopenia Matters: Clinical and Investigative Implications · 2026 · Related
  15. Trifluridine–Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer · Gerald W. Prager · 2023 · 464 citations · Cited by this paper
  16. Prognostic Added Value of GFAP in Patients With Minor Ischemic Stroke · 2026 · Related
  17. Venous thromboembolism in cancer patients: ESMO Clinical Practice Guideline · Anna Falanga · 2023 · 415 citations · Cited by this paper
  18. Management and Prognosis of Patients With Acute Pericarditis in the Emergency Department: A Retrospective, Single‐Centre Study · 2026 · Related
  19. Platelets, Thrombo-Inflammation, and Cancer: Collaborating With the Enemy · Ana-Luisa Palacios-Acedo · 2019 · 286 citations · Cited by this paper
  20. Association of Mitral Annular Disjunction on Magnetic Resonance Imaging With Cardiovascular Outcomes · 2026 · Related
  21. Delayed immune-related events (DIRE) after discontinuation of immunotherapy: diagnostic hazard of autoimmunity at a distance · Marcus Couey · 2019 · 243 citations · Cited by this paper
  22. Incidence, risk factors, and outcomes of venous and arterial thromboembolism in immune checkpoint inhibitor therapy · Florian Moik · 2020 · 233 citations · Cited by this paper
  23. Inflammation promotes resistance to immune checkpoint inhibitors in high microsatellite instability colorectal cancer · Qiaoqi Sui · 2022 · 166 citations · Cited by this paper
  24. Advances and prospects of biomarkers for immune checkpoint inhibitors · Hirohito Yamaguchi · 2024 · 140 citations · Cited by this paper
  25. Systemic Immune–Inflammation Index Predicts Prognosis of Cancer Immunotherapy: Systemic Review and Meta-Analysis · Bao‐Wen Tian · 2022 · 137 citations · Cited by this paper
  26. Venous thromboembolism risk prediction in ambulatory cancer patients: Clinical significance of neutrophil/lymphocyte ratio and platelet/lymphocyte ratio · Patrizia Ferroni · 2014 · 91 citations · Cited by this paper
  27. The relationship between NLR/PLR/LMR levels and survival prognosis in patients with non-small cell lung carcinoma treated with immune checkpoint inhibitors · Na Liu · 2022 · 75 citations · Cited by this paper
  28. Association of Platelet-to-Lymphocyte Ratio and Neutrophil-to-Lymphocyte Ratio with the Risk of Thromboembolism and Mortality in Patients with Cancer · Ella Grilz · 2018 · 67 citations · Cited by this paper
  29. How many people in the US are eligible for and respond to checkpoint inhibitors: An empirical analysis · Alyson Haslam · 2025 · 66 citations · Cited by this paper
  30. A comprehensive analysis of Glasgow Prognostic Score ( GPS )/the modified Glasgow Prognostic Score ( mGPS ) on immune checkpoint inhibitor efficacy among patients with advanced cancer · Yongchao Zhang · 2022 · 32 citations · Cited by this paper
  31. Systemic immune-inflammation index as a predictor of survival in non-small cell lung cancer patients undergoing immune checkpoint inhibition: A systematic review and meta-analysis · Ye Zhang · 2025 · 27 citations · Cited by this paper
  32. Prognostic role of C-reactive protein to albumin ratio in cancer patients treated with immune checkpoint inhibitors: a meta-analysis · Menglu Dai · 2023 · 26 citations · Cited by this paper
  33. Prognostic value of systemic immune-inflammation index (SII) in cancers: a systematic review and meta-analysis · Jianning Tang · 2018 · 24 citations · Cited by this paper
  34. Update on Thrombosis Risk in Patients with Cancer: Focus on Novel Anticancer Immunotherapies · Florian Moik · 2024 · 22 citations · Cited by this paper
  35. Early kinetics of C reactive protein for cancer-agnostic prediction of therapy response and mortality in patients treated with immune checkpoint inhibitors: a multicenter cohort study · Dominik Andreas Barth · 2023 · 21 citations · Cited by this paper
  36. Immune checkpoint inhibitor-associated risk for venous thromboembolism: a comprehensive analysis · Tamara A. Sussman · 2025 · 16 citations · Cited by this paper
  37. Systemic inflammatory markers and volume of enhancing tissue on post-contrast T1w MRI images in differentiating true tumor progression from pseudoprogression in high-grade glioma · Camilla Satragno · 2024 · 12 citations · Cited by this paper
  38. Associations between peripheral whole blood cell counts derived indexes and cancer prognosis: An umbrella review of meta-analyses of cohort studies · Ying-Ying Zhang · 2024 · 12 citations · Cited by this paper
  39. Prognostic role of dynamic changes in inflammatory indicators in patients with non-small cell lung cancer treated with immune checkpoint inhibitors—a retrospective cohort study · Liang Guo · 2024 · 11 citations · Cited by this paper

Source: OpenAlex (CC0)